Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$25.04 - $30.06 $11,117 - $13,346
-444 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$15.31 - $21.12 $1,209 - $1,668
79 Added 21.64%
444 $9,000
Q3 2020

Nov 13, 2020

SELL
$14.88 - $20.13 $1,011 - $1,368
-68 Reduced 15.7%
365 $6,000
Q2 2020

Aug 04, 2020

BUY
$13.31 - $20.51 $306 - $471
23 Added 5.61%
433 $8,000
Q1 2020

May 15, 2020

BUY
$12.98 - $30.25 $584 - $1,361
45 Added 12.33%
410 $6,000
Q3 2018

Oct 26, 2018

BUY
$20.64 - $25.67 $7,533 - $9,369
365 New
365 $9,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.33B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Enterprise Financial Services Corp Portfolio

Follow Enterprise Financial Services Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Financial Services Corp with notifications on news.